Home

Pamiątkowy Krytyczny obcy narasimhan vas Miles Punktualność Znaczący

Novartis working on pan-coronavirus oral treatment, CEO says | Reuters
Novartis working on pan-coronavirus oral treatment, CEO says | Reuters

Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis's Vas Narasimhan on AI, Data Science for Company Operations

Basel is very open to newcomers - Basel Area Business & Innovation
Basel is very open to newcomers - Basel Area Business & Innovation

Novartis CEO Narasimhan says he was 'completely blindsided' by Cohen deal  revelation | FiercePharma
Novartis CEO Narasimhan says he was 'completely blindsided' by Cohen deal revelation | FiercePharma

Vas Narasimhan – Chief Executive Officer – Novartis | LinkedIn
Vas Narasimhan – Chief Executive Officer – Novartis | LinkedIn

Vas Narasimhan – The Chiefs Podcast – Podcast – Podtail
Vas Narasimhan – The Chiefs Podcast – Podcast – Podtail

Novartis to limit M&A spend to 5% of market value | Financial Times
Novartis to limit M&A spend to 5% of market value | Financial Times

Novartis says it knew of Zolgensma data problems before U.S. approval | The  Japan Times
Novartis says it knew of Zolgensma data problems before U.S. approval | The Japan Times

Vas Narasimhan - Ceo of Novartis, Birthday, Childhood - Vas Narasimhan  Biography
Vas Narasimhan - Ceo of Novartis, Birthday, Childhood - Vas Narasimhan Biography

It was never my plan to be the boss of a huge company' - BBC News
It was never my plan to be the boss of a huge company' - BBC News

The 'student' of leadership who seeks to inspire his employees | Financial  Times
The 'student' of leadership who seeks to inspire his employees | Financial Times

Embassy of India, Berne, Switzerland : Events/Photo Gallery
Embassy of India, Berne, Switzerland : Events/Photo Gallery

Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on  sales | FiercePharma
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | FiercePharma

Criticism of Novartis boss Vas Narasimhan is growing - does he have to  leave soon? - Newsy Today
Criticism of Novartis boss Vas Narasimhan is growing - does he have to leave soon? - Newsy Today

Vasant Narasimhan - Wikipedia
Vasant Narasimhan - Wikipedia

Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT

Novartis CEO Vas Narasimhan on M&a and Taking Earlier Risks on New  Technology
Novartis CEO Vas Narasimhan on M&a and Taking Earlier Risks on New Technology

21点のNovartis Ceo Vas Narasimhan Interviewのストックフォト - Getty Images
21点のNovartis Ceo Vas Narasimhan Interviewのストックフォト - Getty Images

Vasant Narasimhan | Novartis
Vasant Narasimhan | Novartis

It was never my plan to be the boss of a huge company' - BBC News
It was never my plan to be the boss of a huge company' - BBC News

Vasant (Vas) Narasimhan, M.D. | African Parks
Vasant (Vas) Narasimhan, M.D. | African Parks

Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery |  Fortune
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune

Novartis CEO in the hotseat after revelation that his company submitted  falsified data to the FDA - The Boston Globe
Novartis CEO in the hotseat after revelation that his company submitted falsified data to the FDA - The Boston Globe

Transforming Standards Of Patient Care And Unbossing The Organisation With  Novartis CEO Vas Narasimhan - Outside Lens
Transforming Standards Of Patient Care And Unbossing The Organisation With Novartis CEO Vas Narasimhan - Outside Lens

novartis: Who is Vas Narasimhan? All about the new global chief executive  of Swiss pharma giant Novartis - The Economic Times
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times

247点のNovartis Ceoのストックフォト - Getty Images
247点のNovartis Ceoのストックフォト - Getty Images

Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash  | Barron's
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's

Novartis's Narasimhan faces his first big test | Evaluate
Novartis's Narasimhan faces his first big test | Evaluate

Vas Narasimhan (@VasNarasimhan) / Twitter
Vas Narasimhan (@VasNarasimhan) / Twitter